Related Experiment Video
Updated: Aug 18, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Successful vaccination against varicella zoster virus prior to kidney transplantation
A Geel1, W Zuidema, T van Gelder
1Department of Internal Medicine, Section Transplantation, Rotterdam, The Netherlands. a.geele@erasmusmc.nl
Background:
In recent years we have observed a number of severe complications of primary varicella-zoster virus (VZV) infections after adult kidney transplantation. We questioned how many patients on the waiting list for kidney transplantation had not been protected against VZV and whether patients with renal insufficiency would be able to develop a specific immune response upon VZV vaccination.
Methods:
We examined the VZV antibody titer of 280 patients on the kidney transplant waiting list. Seronegative kidney transplant candidates were vaccinated twice with a live attenuated varicella vaccine at an interval of 6 weeks.
Conclusions:
Approximately 3% of patients on the waiting list were seronegative for VZV. Vaccination induced no side effects and resulted in a positive serologic response in most patients.
Related Concept Videos
Kidney Transplant I: Introduction
Chickenpox
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
